Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-11-001089
Filing Date
2011-12-19
Accepted
2011-12-19 19:17:23
Documents
1
Period of Report
2011-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-16-2011 form4.html 4  
1 FORM 4 FOR 12-16-2011 form4.xml 4 3708
  Complete submission text file 0001161697-11-001089.txt   5257
Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
HUCKEL HUBERT E MD (Reporting) CIK: 0001121608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 111270430

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations